Cargando…
Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has resulted in >500,000 deaths worldwide, including >125,000 deaths in the U.S. since its emergence in late December 2019 and June 2020. Neither curative...
Autores principales: | Labò, Nazzarena, Ohnuki, Hidetaka, Tosato, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408139/ https://www.ncbi.nlm.nih.gov/pubmed/32629875 http://dx.doi.org/10.3390/cells9071583 |
Ejemplares similares
-
A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy
por: Kusadasi, Nuray, et al.
Publicado: (2020) -
Coagulopathy in SARS-CoV-2 Infected Patients: Implication for the Management of COVID-19
por: Getu, Sisay, et al.
Publicado: (2021) -
Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination
por: Yamada, Shinya, et al.
Publicado: (2022) -
Notch and TGFβ: Functional partners facilitating tumor progression
por: Ohnuki, Hidetaka, et al.
Publicado: (2014) -
Coagulopathy and thromboembolic events in patients with
SARS-CoV-2 infection: pathogenesis and management strategies
por: Allegra, Alessandro, et al.
Publicado: (2020)